EMEA-001379-PIP01-12-M08 - paediatric investigation plan
tedizolid phosphate
PIPHuman
Key facts
- Invented name
- Sivextro
- Active Substance
- tedizolid phosphate
- Therapeutic area
- Infectious diseases
- Decision number
- P/0340/2023
- PIP number
- EMEA-001379-PIP01-12-M08
- Pharmaceutical form(s)
- Film-coated tablet
- Powder for concentrate for solution for infusion
- Powder for oral suspension
- Condition(s) / indication(s)
- Treatment of acute bacterial skin and skin structure infections
- Route(s) of administration
- Oral use
- Intravenous use
- Contact for public enquiries
Merck Sharp & Dohme (Europe) Inc.
Tel. +33 180464738
E-mail: pip.information@merck.com- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date